From the bench to the bedside: ways to improve rituximab efficacyGuillaume Cartron, Philippe Solal‐Céligny|Blood|2004Cited by 518
P3-16-07: Denosumab in Patients with Breast Cancer and Bone Metastases Previously Treated with Zoledronic Acid or Denosumab: Results from the 2-Year Open-Label Extension Treatment Phase of a Pivotal Phase 3 Study.A. Stopeck, Ada Braun, Miguel Martín et al.|Cancer Research|2011Cited by 15